Literature DB >> 21223969

The relationship between IGF-I concentration, cognitive function and quality of life in adults with Prader-Willi syndrome.

I C van Nieuwpoort1, J B Deijen, L M G Curfs, M L Drent.   

Abstract

Mental retardation is one of the clinical characteristics of Prader-Willi syndrome (PWS) and in part of the patients growth hormone deficiency is demonstrable. Cognitive function seems to be influenced by insulin-like growth factor I (IGF-I); however, little is known about cognitive function in relation to IGF-I levels in PWS adults. The aim of the present study was to evaluate cognitive function in adult PWS patients in comparison to healthy siblings and to investigate whether there is a correlation between cognitive function and IGF-I levels. Anthropometric measurements, IGF-I levels, quality of life (QoL), Appetite Assessment Score, IQ (GIT and Raven) and cognitive function (by four subtests of the Cambridge Neuropsychological Automated Testing Battery, CANTAB) were evaluated in PWS patients and their healthy siblings served as control group. PWS patients had significantly lower IGF-I levels, IQ and QoL when compared to controls. Reaction times were longer and performance was worse on CANTAB subtests in PWS adults. IGF-I on one hand and IQ, Appetite Assessment Score and cognitive performance on the other hand seem to be correlated in PWS patients. In conclusion, IGF-I levels, IQ and QoL are significantly lower in PWS subjects when compared to healthy siblings. In PWS adults, temporal as well as prefrontal cognitive functions are impaired. Higher IGF-I levels appear to be related to better intellectual skills and faster temporal memory processing in PWS patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223969     DOI: 10.1016/j.yhbeh.2011.01.001

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  6 in total

1.  Approach to the child with prader-willi syndrome.

Authors:  Jennifer L Miller
Journal:  J Clin Endocrinol Metab       Date:  2012-11       Impact factor: 5.958

2.  Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.

Authors:  Elisabeth M Dykens; Elizabeth Roof; Hailee Hunt-Hawkins
Journal:  J Child Psychol Psychiatry       Date:  2016-08-02       Impact factor: 8.982

Review 3.  Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome.

Authors:  Peter M Wolfgram; Aaron L Carrel; David B Allen
Journal:  Curr Opin Pediatr       Date:  2013-08       Impact factor: 2.856

4.  The effects of long-term resistance exercise on the relationship between neurocognitive performance and GH, IGF-1, and homocysteine levels in the elderly.

Authors:  Chia-Liang Tsai; Chun-Hao Wang; Chien-Yu Pan; Fu-Chen Chen
Journal:  Front Behav Neurosci       Date:  2015-02-10       Impact factor: 3.558

5.  Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial.

Authors:  R J Kuppens; E F Mahabier; N E Bakker; E P C Siemensma; S H Donze; A C S Hokken-Koelega
Journal:  Orphanet J Rare Dis       Date:  2016-11-16       Impact factor: 4.123

6.  Normal Performance of Fmr1 Mice on a Touchscreen Delayed Nonmatching to Position Working Memory Task.

Authors:  Prescott T Leach; Jane Hayes; Michael Pride; Jill L Silverman; Jacqueline N Crawley
Journal:  eNeuro       Date:  2016-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.